Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botulinum toxin vs triamcinolone after PDL laser for hypertrophic erythematous scars
IRCT20220121053776N1Phase 3Completed
- Sponsor
- Iran University of Medical Sciences
- Start
- Feb 2022
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised trial in Hypertrophic Scar (HS) comparing Botulinum toxin plus PDL with Triamcinolone plus PDL (2 arms). Started Feb 2022; status: completed.
02
Drugs
neuronoxtriamcinolone
03
Conditions
Hypertrophic Scar (HS)
Beyond the preview
Go deeper on IRCT20220121053776N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20220121053776N1.